Therapeutic Asset Ratings

6,371 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
PANITUMUMAB Colon Carcinoma	IFOM ETS - The AIRC Institute of Molecular Oncology	P3	B (63)
PANITUMUMAB Metastatic Neoplasm	Amgen	P3	B (63)
Remternetug Alzheimer Disease	Washington University School of Medicine	P3	B (63)
Rilvegostomig Non-Small Cell Lung Carcinoma	AstraZeneca	P3	B (63)
Serplulimab Rectal Carcinoma	Fudan University	P3	B (63)
Sugemalimab Non-Small Cell Lung Carcinoma	Shanghai Pulmonary Hospital, Shanghai, China	P3	B (63)
Surovatamig Large B-Cell Lymphoma	AstraZeneca	P3	B (63)
Tafasitamab Diffuse Large B-Cell Lymphoma	Brown University	P3	B (63)
Tislelizumab Lung Cancer	Gustave Roussy, Cancer Campus, Grand Paris	P3	B (63)
Tislelizumab Ovarian Cancer	West China Hospital	P3	B (63)
Tocilizumab Non-Hodgkin Lymphoma	Hoffmann-La Roche	P3	B (63)
Toripalimab Hepatocellular Carcinoma	Sun Yat-sen University	P3	B (63)
Toripalimab Radiotherapy	Northern Jiangsu People's Hospital	P3	B (63)
Atezolizumab Refractory Malignant Neoplasm	Bionoxx Inc.	P2	B (63)
Cetuximab Esophageal Adenocarcinoma	BeOne Medicines	P2	B (63)
Cetuximab Esophageal Squamous Cell Carcinoma	Hummingbird Bioscience	P2	B (63)
Cetuximab BRAF V600E	Tianjin Medical University Cancer Institute and Hospital	P2	B (63)
DARATUMUMAB Myelodysplastic Syndrome	City of Hope Medical Center	P2	B (63)
Durvalumab Digestive System Cancer	M.D. Anderson Cancer Center	P2	B (63)
Durvalumab Luminal B Breast Carcinoma	Jules Bordet Institute	P2	B (63)
Ezabenlimab Metastatic Malignant Neoplasm	Boehringer Ingelheim	P2	B (63)
IMMUNOGLOBULIN G1, ANTI-(HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR TYPE VEGFR-2 EXTRACELLULAR DOMAIN) (HUMAN MONOCLONAL IMC-1121B .GAMMA.-CHAIN), DISULPHIDE WITH HUMAN MONOCLONAL IMC-1121B .KAPPA.-CHAIN, DIMER Cancer	Eli Lilly and Company	P2	B (63)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER Hematopoietic And Lymphoid Cell Neoplasm	Masonic Cancer Center, University of Minnesota	P2	B (63)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER Lymphoproliferative Syndrome	Emory University	P2	B (63)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER Myelodysplastic/Myeloproliferative Neoplasm	Prelude Therapeutics	P2	B (63)

Showing 601 to 625 of 6,371 assets

PreviousPage 25 of 255Next